Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder.
- Published In:
- The international journal of neuropsychopharmacology, 29(2) (2026)
- Authors:
- Tyler, Ryan E, Pfaff, Rabea K, Khan, Raja Muhammad Naseer, Loften, Anna, Zurick, Ryan, Zeng, Yi, Arisa, Oluwatobi T, Harvey, Charlotte, Akhlaghi, Fatemeh, Figg, William D, Farokhnia, Mehdi, Leggio, Lorenzo
- Database ID:
- RPEP-16286
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16286APA
Tyler, Ryan E; Pfaff, Rabea K; Khan, Raja Muhammad Naseer; Loften, Anna; Zurick, Ryan; Zeng, Yi; Arisa, Oluwatobi T; Harvey, Charlotte; Akhlaghi, Fatemeh; Figg, William D; Farokhnia, Mehdi; Leggio, Lorenzo. (2026). Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder.. The international journal of neuropsychopharmacology, 29(2). https://doi.org/10.1093/ijnp/pyaf081
MLA
Tyler, Ryan E, et al. "Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder.." The international journal of neuropsychopharmacology, 2026. https://doi.org/10.1093/ijnp/pyaf081
RethinkPeptides
RethinkPeptides Research Database. "Pharmacokinetic and pharmacodynamic results from a randomize..." RPEP-16286. Retrieved from https://rethinkpeptides.com/research/tyler-2026-pharmacokinetic-and-pharmacodynamic-results
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.